Published in Br J Surg on April 01, 1988
Enhanced expression of matrilysin, collagenase, and stromelysin-1 in gastrointestinal ulcers. Am J Pathol (1996) 1.72
Distribution of the matrix metalloproteinases stromelysin, gelatinases A and B, and collagenase in Crohn's disease and normal intestine. J Clin Pathol (1994) 1.60
Distinct localization of collagenase and tissue inhibitor of metalloproteinases expression in wound healing associated with ulcerative pyogenic granuloma. J Clin Invest (1992) 1.45
Postoperative changes in collagen synthesis in intestinal anastomoses of the rat: differences between small and large bowel. Gut (1991) 1.07
Serum metalloproteinases and their inhibitors: markers for malignant potential. Br J Cancer (1994) 0.94
Divergent patterns of matrix metalloproteinase activity during wound healing in ileum and colon of rats. Gut (1996) 0.82
Ascorbic acid iontophoresis for chondral gain in rats with arthritis. Acta Ortop Bras (2014) 0.75
Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. J Biol Chem (1996) 3.00
Genetic instability in patients with metachronous colorectal cancers. Br J Surg (1997) 2.34
Characterization of gelatinase from pig polymorphonuclear leucocytes. A metalloproteinase resembling tumour type IV collagenase. Biochem J (1989) 1.89
Detection and enumeration of circulating tumour cells in colorectal cancer. Br J Surg (1993) 1.77
Technical report: spiral CT pneumocolon for suspected colonic neoplasms. Clin Radiol (1996) 1.77
Immunolocalization of tissue inhibitor of metalloproteinases (TIMP) in human cells. Characterization and use of a specific antiserum. J Cell Sci (1985) 1.73
Endoscopic laser palliation for advanced malignant dysphagia. Gut (1987) 1.67
Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1. Implications for regulation of matrix degradation in liver. J Clin Invest (1992) 1.62
The contrasting mechanisms of colonic collagen damage between photodynamic therapy and thermal injury. Photochem Photobiol (1987) 1.61
Distribution of the matrix metalloproteinases stromelysin, gelatinases A and B, and collagenase in Crohn's disease and normal intestine. J Clin Pathol (1994) 1.60
Survey of management in acute upper gastrointestinal haemorrhage. J R Soc Med (1980) 1.52
Characterization of a specific antiserum to rabbit stromelysin and demonstration of the synthesis of collagenase and stromelysin by stimulated rabbit articular chondrocytes. Coll Relat Res (1986) 1.50
Detection of free malignant cells in the peritoneal cavity before and after resection of colorectal cancer. Dis Colon Rectum (1994) 1.49
Is colonoscopy necessary in diverticular disease? Lancet (1984) 1.48
Pathogenesis and clinical management of hereditary non-polyposis colorectal cancer. Br J Surg (2002) 1.45
Influence of temporary faecal diversion on long-term survival after curative surgery for colorectal cancer. Br J Surg (1995) 1.42
Photodynamic therapy in the normal rat colon with phthalocyanine sensitisation. Br J Cancer (1987) 1.38
Loss of cell-cell and cell-matrix adhesion molecules in colorectal cancer. Br J Cancer (1993) 1.36
Secretion of 72 kDa type IV collagenase/gelatinase by cultured human lipocytes. Analysis of gene expression, protein synthesis and proteinase activity. Biochem J (1992) 1.35
Commitment to expression of the metalloendopeptidases, collagenase and stromelysin: relationship of inducing events to changes in cytoskeletal architecture. J Cell Biol (1986) 1.29
Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: associated activation of gelatinase A, gelatinase B and collagenase 3. Biochem J (1998) 1.29
Binding of latent and high Mr active forms of stromelysin to collagen is mediated by the C-terminal domain. J Cell Sci (1991) 1.26
The clinical importance and prognostic implications of microsatellite instability in sporadic cancer. Eur J Surg Oncol (2003) 1.24
Purification and characterization of human 72-kDa gelatinase (type IV collagenase). Use of immunolocalisation to demonstrate the non-coordinate regulation of the 72-kDa and 95-kDa gelatinases by human fibroblasts. Biol Chem Hoppe Seyler (1991) 1.24
Characterization of a specific antiserum for mammalian collagenase from several species: immunolocalization of collagenase in rabbit chondrocytes and uterus. J Cell Sci (1986) 1.22
Current concepts in metastasis. Gut (1994) 1.21
Selective necrosis in dimethylhydrazine-induced rat colon tumors using phthalocyanine photodynamic therapy. Gastroenterology (1990) 1.21
Neurochemical coding in the small intestine of patients with Crohn's disease. Gut (1997) 1.21
Metalloproteinases and tissue damage. Br J Rheumatol (1991) 1.18
Role and regulation of metalloproteinases in connective tissue turnover. Biochem Soc Trans (1990) 1.17
Comparison of distribution and photodynamic effects of di- and tetra-sulphonated aluminium phthalocyanines in normal rat colon. Photochem Photobiol (1991) 1.16
MT1-MMP on the cell surface causes focal degradation of gelatin films. FEBS Lett (1998) 1.15
Increased endothelin-1 in colorectal cancer and reduction of tumour growth by ET(A) receptor antagonism. Br J Cancer (2001) 1.15
Cathepsin D in cartilage: the immunohistochemical demonstration of extracellular enzyme in normal and pathological conditions. J Cell Sci (1974) 1.15
The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers. Br J Cancer (2005) 1.15
Endoscopic treatment of inoperable colorectal cancers with the Nd YAG laser. Br J Surg (1986) 1.12
Secretion and localization of cathepsin D in synovial tissues removed from rheumatoid and traumatized joints. An immunohistochemical study. Arthritis Rheum (1977) 1.11
Immunolocalization of metalloproteinases and their inhibitor in the rabbit growth plate. J Bone Joint Surg Am (1989) 1.11
Photodynamic therapy for colorectal cancer: a quantitative pilot study. Br J Surg (1990) 1.11
Raised endothelin 1 levels in patients with colorectal liver metastases. Br J Surg (1998) 1.10
Gelatinase (type IV collagenase) immunolocalization in cells and tissues: use of an antiserum to rabbit bone gelatinase that identifies high and low Mr forms. J Cell Sci (1989) 1.10
The effects of selective inhibitors of matrix metalloproteinases (MMPs) on bone resorption and the identification of MMPs and TIMP-1 in isolated osteoclasts. J Cell Sci (1994) 1.10
Metalloproteinase and tissue inhibitor of metalloproteinase expression in the murine STR/ort model of osteoarthritis. Osteoarthritis Cartilage (2002) 1.09
Matrix metalloproteinase-2 activation in human hepatic fibrosis regulation by cell-matrix interactions. Hepatology (1999) 1.06
Human osteoblasts in culture synthesize collagenase and other matrix metalloproteinases in response to osteotropic hormones and cytokines. J Cell Sci (1992) 1.04
The cytoskeletal elements of human retinal pigment epithelium: in vitro and in vivo. J Cell Sci (1988) 1.00
Connective tissue degradation in health and periodontal disease and the roles of matrix metalloproteinases and their natural inhibitors. Adv Dent Res (1994) 1.00
Comparison of the effects of vitamin A and its analogs upon rabbit ear cartilage in organ culture and upon growth of the vitamin A-deficient rat. J Lipid Res (1974) 0.99
Generation and novel distribution of matrix metalloproteinase-derived aggrecan fragments in porcine cartilage explants. J Biol Chem (2000) 0.99
Extracellular localization of cathepsin D in ossifying cartilage. Calcif Tissue Res (1973) 0.98
Anorectal injury following pelvic radiotherapy. Br J Surg (2001) 0.98
Plasma gastrin and acid secretion in man following stimulation by food, meat extract, and insulin. Gut (1972) 0.98
Stromelysin-2 is upregulated during normal wound repair and is induced by cytokines. J Invest Dermatol (2000) 0.97
Morphologic examination of mesenchymal cells in healing wounds of normal and tight skin mice. Am J Pathol (1986) 0.96
Detection of occult nodal metastases in patients with colorectal carcinoma. Cancer (1990) 0.96
Stromelysin-1 (MMP-3) and stromelysin-2 (MMP-10) expression in developing human bone: potential roles in skeletal development. Bone (1998) 0.95
Tissue inhibitor of metalloproteinases (TIMP) regulates extracellular type I collagen degradation by chondrocytes and endothelial cells. J Cell Sci (1987) 0.95
Evidence that extracellular cathepsin D is not responsible for the resorption of cartilage matrix in culture. Biochim Biophys Acta (1982) 0.95
Plasminogen activators in human colorectal neoplasia. Br Med J (Clin Res Ed) (1986) 0.94
Anal intraepithelial neoplasia. Br J Surg (2005) 0.94
Metalloproteinases and cancer invasion and metastasis. Int J Cancer (1989) 0.94
Experimental model for scleritis. Arch Ophthalmol (1979) 0.93
Long-term outcome of patients presenting with acute complications of diverticular disease. Ann R Coll Surg Engl (1994) 0.92
Helical CT pneumocolon to assess colonic tumors: radiologic-pathologic correlation. AJR Am J Roentgenol (1998) 0.92
Metalloproteinases are not involved in the phagocytosis of collagen fibrils by fibroblasts. Matrix (1989) 0.92
Adequate internal sphincterotomy for chronic anal fissure: subcutaneous or open technique? Br J Surg (1984) 0.92
Rabbit cranial suture fibroblasts under tension express a different collagen phenotype. Arch Oral Biol (1982) 0.91
Production of collagenase by human osteoblasts and osteoclasts in vivo. Bone (1996) 0.90
Pinworm infestation of the appendix. Br J Surg (1973) 0.90
Plasminogen activators in experimental colorectal neoplasia: a role in the adenoma-carcinoma sequence? Gut (1987) 0.90
Metachronous colorectal cancers. Br J Surg (1998) 0.90
Localisation of matrix metalloproteinases and TIMP-2 in resorbing mouse bone. Cell Tissue Res (2000) 0.89
Actin filaments in normal dermis and during wound healing. Am J Pathol (1987) 0.89
Preparation of antibody fragments: conditions for proteolysis compared by SDS slab-gel electrophoresis and quantitation of antibody yield. J Immunol Methods (1978) 0.89
Bacterial antigens induce collagenase and prostaglandin E2 synthesis in human gingival fibroblasts through a primary effect on circulating mononuclear cells. Infect Immun (1987) 0.88
Immunolocalization of collagenase and tissue inhibitor of metalloproteinases (TIMP) in hypertrophic scar tissue. Br J Dermatol (1986) 0.86
Proceedings: Extracellular release of cathepsin D from cells in human normal and rheumatoid. Ann Rheum Dis (1974) 0.86
Internal sphincterotomy for chronic anal fissure: long term effects on anal pressure. Br J Surg (1986) 0.86
Crypt cell carcinoma of the appendix. Eur J Surg Oncol (1992) 0.85
The distribution of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal cancer. Surg Oncol (1995) 0.85
A double-blind randomized placebo-controlled trial of oral indoramin to treat chronic anal fissure. Colorectal Dis (2001) 0.84
Proximal gastric vagotomy after five years. Gut (1981) 0.84
Intra-abdominal sepsis and survival after surgery for colorectal cancer. Br J Surg (1994) 0.83
Endoscopic Nd:YAG laser treatment of rectosigmoid cancer. Gut (1990) 0.83
Distribution of matrix metalloproteinases and their inhibitor, TIMP-1, in developing human osteophytic bone. J Anat (1997) 0.83
Immunolocalization of matrix metalloproteinases and TIMP-1 (tissue inhibitor of metalloproteinases) in human gingival tissues from periodontitis patients. J Periodontal Res (1994) 0.83
Two cases of solitary metastases from carcinoma of the lung presenting as primary colonic tumours. Br J Surg (1996) 0.83
Tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) distribution in normal and pathological human bone. Bone (1999) 0.83
Photodynamic therapy for colorectal disease. Int J Colorectal Dis (1989) 0.83
Conservative surgery in 100 patients with bleeding peptic ulcer. Br J Surg (1971) 0.82
Matrix metalloproteinases in the formation of human synovial joint cavities. J Anat (1996) 0.82
Neuromyogenic properties of the internal anal sphincter: therapeutic rationale for anal fissures. Gut (2000) 0.82